Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity — Stella

Home/Parkinson Disease/

View on ClinicalTrials.gov

Recruiting

Back to Parkinson Disease trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Germany

University Hospital of Bonn, Bonn, North Rhine West-Falia

Key details

Sponsor

University Hospital, Bonn

Collaborators

Radboud University Medical Center, Medical University Innsbruck

Enrollment target

~130 participants

Started

December 2025

Primary completion

December 2028

Age range

50 Years – 80 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.